A Japan-based pharmaceutical developer focused on treatments for neurological, immunological, and metabolic diseases, with global attention around its ALS therapy Radicava. The company operates as part of Mitsubishi Chemical Group and markets prescription medicines primarily in Japan and the United ...
2 members of Congress have disclosed 3 trades in Mitsubishi Tanabe Pharma Corp Sponsored ADR (MTPC), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-20 | Rohit Khanna | sell | $1K – $15K |
| 2026-03-20 | Rohit Khanna | buy | $1K – $15K |
| 2022-05-10 | ROBERT J. WITTMAN | buy | $1K – $15K |